- This event has passed.
CVG 2022 Seminar-3:Quality-by-Design Approaches to Develop a Robust Oral Formulation
March 23, 2022 @ 5:30 pm to 6:30 pm
Speaker: Dr. Kwok Chow
Seminar will be conducted online via Zoom @ 5:30 pm EDT
This presentation will discuss how to formulate an oral drug product following a Quality-by-Design approach. Mechanistic and risk assessment strategies to evaluate and characterize drug substance for product development will be provided. The use of a decision tree based on API properties for dosage form design will also be discussed. Topics and examples related to effective use of statistical design of experiment and target product profile will also be included in the presentation.
Dr. Kwok Chow is an expert in product development and drug delivery systems. Currently, he is the President of Covar Pharmaceuticals Inc. and Power Pharma Coating Inc. He has served as a Scientific Advisor to the Editors of the Journal of Pharmaceutical Sciences and a core member of the Scientific Advisory Committee on Pharmaceutical Sciences and Clinical Pharmacology at Health Canada.
Dr. Chow was the Senior Director of Global PDS Technology and Alliances at Patheon Inc. with the responsibility of introducing new technologies, establishing strategic alliances and supporting the development of challenging molecules. Before this Dr. Chow was Director of Formulation Development, responsible for all formulation development activities in Patheon, Canada, and specializing in a wide range of products including tablets, soft gelatin capsules, liquids, topicals, suspensions, nasal sprays, powder for reconstitution, combination and fast dissolving formulations, etc. Dr. Chow also developed a screening program (SoluPath) to improve bioavailability of poorly soluble drugs.
Dr. Chow began his career at Glaxo where he led the development of new chemical entities and line extension products for North American, European, Japan and Asia Pacific markets. Dr. Chow received his B.S. in Pharmacy from the University of Minnesota and his Ph.D. in Industrial Pharmacy from Professor David Grant at the University of Toronto. Dr. Chow also serves as an Adjunct Professor at the Chinese University of Hong Kong, School of Pharmacy.